In the latest funding developments in China, Shanghai-based pharma company Harbour BioMed said it has completed Series A+ round of financing led by Chinese private equity firm CDH Investments, while Hive Box has raised $323 million in a strategic financing round from a group of investors.
CDH Investments backs Harbour BioMed
Shanghai-based pharma company Harbour BioMed on Monday announced that it has completed Series A+ round of financing led by Chinese private equity firm CDH Investments, with participation from Advantech Capital.
Financial details were not disclosed.
Established in 2016, Harbour BioMed is a global biopharmaceutical company discovering and developing innovative therapeutics for cancer, with a focus on immuno-oncology, and immunological diseases.
It started with $50 million A round financing, and acquired Harbour Antibodies BV and its subsidiaries, one of the few companies that owns technologies for generating fully human monoclonal antibodies, of both conventional as well as heavy chain only form, it said in a statement.
“We are building a top-notch antibody discovery and technology team specialized in Immuno-Oncology and Immunology, developing a robust internal pipeline targeting global market, in licensing innovative assets to address high unmet needs for the China market, and forging new partnerships based on internal technology platforms,” said Dr. Jingsong Wang, CEO of Harbour BioMed.
The company’s current investors include Atlas Venture, Advantech Capital, Legend Capital, CDH Investments and the founding team. Harbour BioMed is headquartered with R&D Centers in China. It also has a Business Operation and Innovation Center in Boston, and an Antibody Technology Innovation Center located in Rotterdam, The Netherlands.
Hive Box gets $323m financing
Chinese logistics company Hive Box has raised $323 million in a strategic financing round from a group of investors including Eastern Bell Venture Capital, Global Logistic Properties (GLP), STO Express, SF Express, Yunda Express, and Long Star Growth Group Limited, reported CMN.
Other Chinese private companies too participated in the financing.
CDH Investments had reportedly led a $360 million (RMB2.5 billion) series A funding round in Hive Box a year ago, which operates a network of self-service package drop-off and pick-up stations across China.
Hive Box was formed in June 2015 through a joint investment by Chinese courier companies SF Express Co. Ltd, STO Express, ZTO Express and Yunda Express, as well as GLP, with an aim to provide the best express delivery experience by developing a 24-hour self-service open platform for express delivery companies and e-commerce logistics.